Cargando…
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
Context. Calcifediol has been proposed as a potential treatment for COVID-19 patients. Objective: To compare the administration or not of oral calcifediol on mortality risk of patients hospitalized because of COVID-19. Design: Retrospective, multicenter, open, non-randomized cohort study. Settings:...
Autores principales: | Alcala-Diaz, Juan F., Limia-Perez, Laura, Gomez-Huelgas, Ricardo, Martin-Escalante, Maria D., Cortes-Rodriguez, Begoña, Zambrana-Garcia, Jose L., Entrenas-Castillo, Marta, Perez-Caballero, Ana I., López-Carmona, Maria D., Garcia-Alegria, Javier, Lozano Rodríguez-Mancheño, Aquiles, Arenas-de Larriva, Maria del Sol, Pérez-Belmonte, Luis M., Jungreis, Irwin, Bouillon, Roger, Quesada-Gomez, Jose Manual, Lopez-Miranda, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224356/ https://www.ncbi.nlm.nih.gov/pubmed/34064175 http://dx.doi.org/10.3390/nu13061760 |
Ejemplares similares
-
Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2022) -
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
por: Entrenas Castillo, Marta, et al.
Publicado: (2020) -
Calcifediol Cornerstone of the Vitamin D Endocrine System
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2023) -
Calcifediol for Use in Treatment of Respiratory Disease
por: Entrenas-Castillo, Marta, et al.
Publicado: (2022) -
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients
por: Loucera, Carlos, et al.
Publicado: (2021)